Drug Approval Tracking

Drug approvals in the myeloma space from the 1960-2000 was almost zero but since 2003 we have seen 19 new approvals, which are dramatically changing the therapeutic landscape of multiple myeloma and resulting in significant improvements in patient outcomes.